Characterization of the MHC class I cross-presentation pathway for cell-associated antigens by human dendritic cells.
about
Identification of proteases employed by dendritic cells in the processing of protein purified derivative (PPD)Cross-Presentation of Cell-Associated Antigens by MHC Class I in Dendritic Cell SubsetsToll-like receptors: key players in antiviral immunityMechanisms of HIV protein degradation into epitopes: implications for vaccine designAntitumor immune responses mediated by dendritic cells: How signals derived from dying cancer cells drive antigen cross-presentationHuman neonatal dendritic cells are competent in MHC class I antigen processing and presentation.Generation and characterization of a defective HIV-1 Virus as an immunogen for a therapeutic vaccine.Diversity in the acute CD8 T cell response to vaccinia virus in humans.Pseudovirion particle production by live poxvirus human immunodeficiency virus vaccine vector enhances humoral and cellular immune responses.Electroporation as a vaccine delivery system and a natural adjuvant to intradermal administration of plasmid DNA in macaquesSecreted immunodominant Mycobacterium tuberculosis antigens are processed by the cytosolic pathway.Implications of ER stress, the unfolded protein response, and pro- and anti-apoptotic protein fingerprints in human monocyte-derived dendritic cells treated with alcohol.Cross-presentation of synthetic long peptides by human dendritic cells: a process dependent on ERAD component p97/VCP but Not sec61 and/or Derlin-1.Variable processing and cross-presentation of HIV by dendritic cells and macrophages shapes CTL immunodominance and immune escape.Heroin-Induces Differential Protein Expression by Normal Human Astrocytes (NHA).Cross-presentation: dendritic cells and macrophages bite off more than they can chew!The apoptotic-cell receptor CR3, but not alphavbeta5, is a regulator of human dendritic-cell immunostimulatory function.Antigen processing and remodeling of the endosomal pathway: requirements for antigen cross-presentation.Induction of potent CD8+ T-cell responses by novel biodegradable nanoparticles carrying human immunodeficiency virus type 1 gp120.Dendritic cells, viruses, and the development of atopic disease.Understanding orthopoxvirus interference with host immune responses to inform novel vaccine design.Complement Opsonization Promotes Herpes Simplex Virus 2 Infection of Human Dendritic Cells.CD8 cytotoxic T cells in cutaneous leishmaniasis.Tolerogenic Donor-Derived Dendritic Cells Risk Sensitization In Vivo owing to Processing and Presentation by Recipient APCs.The cell biology of cross-presentation and the role of dendritic cell subsets.RAB43 facilitates cross-presentation of cell-associated antigens by CD8α+ dendritic cells.IFN-gamma enables cross-presentation of exogenous protein antigen in human Langerhans cells by potentiating maturation.Dendritic cells and macrophages are productively infected by poliovirus.A modular and combinatorial view of the antigen cross-presentation pathway in dendritic cells.Into the intracellular logistics of cross-presentation.Dendritic cell engineering for tumor immunotherapy: from biology to clinical translation.Tissue dendritic cells as portals for HIV entry.Understanding MHC class I presentation of viral antigens by human dendritic cells as a basis for rational design of therapeutic vaccines.Antigen Cross-Presentation and Heat Shock Protein-Based Vaccines.The ongoing saga of the mechanism(s) of MHC class I-restricted cross-presentation.Spatial separation of the processing and MHC class I loading compartments for cross-presentation of the tumor-associated antigen HER2/neu by human dendritic cells.The Biology and Underlying Mechanisms of Cross-Presentation of Exogenous Antigens on MHC-I Molecules.Myeloid dendritic cells (DCs) of mice susceptible to paracoccidioidomycosis suppress T cell responses whereas myeloid and plasmacytoid DCs from resistant mice induce effector and regulatory T cells.TLR and nucleotide-binding oligomerization domain-like receptor signals differentially regulate exogenous antigen presentation.Delivery of Exogenous Antigens to Induce Cytotoxic CD8+ T Lymphocyte Responses.
P2860
Q24803671-904C9285-FBDF-4EEC-A297-3677A8611C3BQ26799991-51A7A485-94D3-4D7D-A299-AEDA163B9421Q26865983-9BC2C6C0-3395-4AFE-9E91-CE16A134C71FQ26866505-2218A2ED-6B22-4308-A209-45699F8BEC6FQ27026193-49D1F1A7-6117-4C98-8A94-108D56B189FFQ30834544-834EE4FF-D2E6-428C-BD29-C50A803EBCBAQ31106756-9395D05F-D0BE-4EBB-86FF-3D033C3CD39FQ33227607-8F8E4E6C-0AF5-41F7-B818-BED90364FDFFQ33755041-B4FCDA28-D94E-459F-AE9D-72AD9A7BBF1CQ33829920-6BE26507-B434-42F5-B749-8D9443EF585FQ34335032-7D2CE1F9-9E9A-40D6-8F32-1F575641A51AQ34336596-C1632370-3E16-481F-B216-E6DDBD5C573BQ35108299-40AFE71F-A0DF-4429-81E1-931026A1AA6FQ35579689-6025FD2F-D045-44A5-9EB5-8D8A288BE5F9Q35599877-C1BA8D6E-4616-4A7A-ADFC-391B9023613BQ35804451-A2C05145-EF39-4305-934E-21ABF0B0C6B8Q35849871-D88DC0C0-FF41-47E1-9289-5233235A2958Q35928276-C6D1A941-EA2A-434E-9619-276CB5C78B87Q36098933-7C31D708-7571-49DD-A58C-4FC2E40DFB1AQ36340296-9403D506-52EE-4106-A2A3-243A5D601A50Q36728801-9F1752A0-E9EB-40C5-BCFC-EE9100AE2C88Q36878921-1175BD36-6292-41E5-A4DB-E38DD3E34EE0Q37016265-DD8475F3-3A6A-48BF-A2F9-3A1A7C7D80EDQ37077325-416F117D-AF41-4445-8472-EDE0C43FD7B3Q37082455-BC676FCB-557F-42A2-965F-FCAEB80A3AA8Q37500322-D51324D0-1EAF-4CA2-AF72-E66362CC5F82Q37569023-E32CE6DB-EFD6-47DC-B443-C3CA4229505EQ37746786-8CACD406-37C8-4BCD-A40D-4EAD5CA8DC07Q37903403-410CD239-8039-43E1-AB27-BB6405E1770EQ38008356-26456D81-21D2-4B24-B17A-C48AE4C0353BQ38031280-C6E9BE8F-A7EE-4365-A1F4-9A6CB8D8DD02Q38125962-28F14173-C01F-464C-9179-1309940B5221Q38209325-C442F792-9C99-4440-AD1E-60FE307E02FEQ38620773-5E83B713-A7F4-4B62-82BD-E8B514878B19Q38772920-31C3DD72-0F69-49F9-91E5-CC101C376E6DQ39014554-BBB93160-BF51-4CBF-B357-AECCFF8C81AAQ39104926-E4FA27D4-207F-4F40-90FA-D5BF399377A6Q40227296-BD4B2D8C-43A5-47F5-BB05-3EE3AC92E966Q40227414-FFF7A46F-85D4-4F13-8D30-68751F609642Q40700979-00678564-96AA-48F6-A00C-727FCFA7FD8F
P2860
Characterization of the MHC class I cross-presentation pathway for cell-associated antigens by human dendritic cells.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Characterization of the MHC cl ...... gens by human dendritic cells.
@en
Characterization of the MHC cl ...... gens by human dendritic cells.
@nl
type
label
Characterization of the MHC cl ...... gens by human dendritic cells.
@en
Characterization of the MHC cl ...... gens by human dendritic cells.
@nl
prefLabel
Characterization of the MHC cl ...... gens by human dendritic cells.
@en
Characterization of the MHC cl ...... gens by human dendritic cells.
@nl
P2093
P1433
P1476
Characterization of the MHC cl ...... gens by human dendritic cells.
@en
P2093
Catherine Sanders
Daniel G Kavanagh
Jean Francois Fonteneau
Margareta Lirvall
Nina Bhardwaj
P304
P356
10.1182/BLOOD-2003-06-1801
P407
P577
2003-08-21T00:00:00Z